In contrast, the higher proportion of missense mutations in H/L patients, particularly within SMAD2 and CTNNB1, may result in more nuanced functional alterations that contribute to tumor progression through different biological mechanisms. The gene discussed is CTNNB1; the disease is neoplasm.